MLchartDataset catalogue

Aerosolized aldesleukin

Term · Oncology and biomedicine · MLC-T-ONC-009720

An aerosol formulation of aldesleukin, a recombinant form of interleukin-2 (IL-2), with potential immunostimulating activity. Upon IL-2 inhalation, this cytokine activates lymphokine-activated killer cells and natural killer cells, and induces expression of cytotoxic cytokines, such as interferon-gamma and transforming growth factor-beta. This may eventually halt tumor cell growth. Localized administration of IL-2 may decrease toxicity and increase efficacy.

Table 1. Record
IdentifierMLC-T-ONC-009720
FieldOncology and biomedicine
Synonymsaerosolized recombinant IL-2
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009720",
  "term": "Aerosolized aldesleukin",
  "field": "Oncology and biomedicine",
  "definition": "An aerosol formulation of aldesleukin, a recombinant form of interleukin-2 (IL-2), with potential immunostimulating activity. Upon IL-2 inhalation, this cytokine activates lymphokine-activated killer cells and natural killer cells, and induces expression of cytotoxic cytokines, such as interferon-gamma and transforming growth factor-beta. This may eventually halt tumor cell growth. Localized administration of IL-2 may decrease toxicity and increase efficacy.",
  "synonyms": [
    "aerosolized recombinant IL-2"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/aerosolized-aldesleukin/"
}

Record 511 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.